TOCIT XR 11 mg contains Tofacitinib 11 mg (Extended Release), an immunosuppressant medicine used to treat autoimmune inflammatory diseases.
Tofacitinib works by blocking Janus kinase (JAK) enzymes, which are involved in immune system signaling. By reducing overactive immune responses, it helps decrease inflammation, pain, swelling, and joint damage.
Rheumatoid arthritis
Psoriatic arthritis
Ulcerative colitis (in selected cases)
Other autoimmune inflammatory disorders (as prescribed by a specialist)
Usual dose:
Dose may be adjusted by the doctor in kidney or liver disease or based on response.
Take once daily at the same time each day.
Swallow whole with water (do not crush or chew).
Can be taken with or without food.
Do not stop suddenly without doctor advice.
Upper respiratory infections (cold, sore throat)
Headache
Nausea
Diarrhea
Increased risk of infections
Increased cholesterol levels
Increased risk of serious infections (including tuberculosis)
Requires regular blood tests (blood count, liver, lipid profile)
Avoid live vaccines during treatment
Not suitable for patients with active severe infections
Use only under specialist supervision